Prevalence and Correlates of Long COVID Symptoms Among US Adults

Roy H. Perlis, Mauricio Santillana, Katherine Ognyanova, et al
JAMA Network
2022;5(10):e2238804
October 27, 2024

Abstract

Importance  Persistence of COVID-19 symptoms beyond 2 months, or long COVID, is increasingly recognized as a common sequela of acute infection.

Objectives  To estimate the prevalence of and sociodemographic factors associated with long COVID and to identify whether the predominant variant at the time of infection and prior vaccination status are associated with differential risk.

Design, Setting, and Participants  This cross-sectional study comprised 8 waves of a nonprobability internet survey conducted between February 5, 2021, and July 6, 2022, among individuals aged 18 years or older, inclusive of all 50 states and the District of Columbia.

Main Outcomes and Measures  Long COVID, defined as reporting continued COVID-19 symptoms beyond 2 months after the initial month of symptoms, among individuals with self-reported positive results of a polymerase chain reaction test or antigen test.

Related publications